Shinya Manaka
Research Subjects
Shinya Manaka has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Emiko Kobayashi
Department of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan
1 shared publication - Kazuhiro Ogata
Department of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama, Japan
1 shared publication - Masaaki Shiina
Graduate School of Medicine, Yokohama City University, Fuku-ura 3-9, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan
1 shared publication - Masako Ikawa
Department of Oral Surgery, Shizuoka-Shimizu Municipal Hospital, Shizuoka, Japan
1 shared publication - Naomichi Matsumoto
Department of Human Genetics Yokohama City University Graduate School of Medicine Yokohama Japan
1 shared publication - Noboru Imai
Japanese Red Cross Shizuoka Hospital
1 shared publication
Latest Publications
- Open Access
- 23 April 2015
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 16 (1) , 1-9
Short-lasting unilateral neuralgiform headache attacks with ispilateral facial flushing is a new variant of paroxysmal extreme pain disorder
We encountered a 5-year-old girl who had short-lasting, severe, unilateral temporal headaches with ipsilateral lacrimation, nasal congestion and rhinorrhoea, and facial flushing after severe attacks. Family history revealed similar short-lasting, severe headaches in an older brother, younger sister, mother, maternal aunt, and maternal grandfather’s brother. We performed routine laboratory examinations and electrophysiological and radiological studies for three children, and whole-exome sequencing to determine the genetic causality in this family. Focal hyperperfusion of the right trigeminal root entry zone was seen during a right-sided attack in one child, while left-sided temporal headache attacks were provoked by bilateral electrical stimulation of the upper extremities in another. We identified a novel SCN9A mutation (NM_002977: c.5218G>C, p.Val1740Leu) in all affected family members, but not in any of the unaffected members. SCN9A encodes the voltage-gated sodium-channel type IX alpha subunit known as Nav1.7. Gain-of-function mutations in Nav1.7 are well known to cause paroxysmal extreme pain disorder (PEPD), a painful Na-channelopathy characterized by attacks of excruciating deep burning pain in the rectal, ocular, or jaw areas. The SCN9A mutation suggests that our patients had a phenotype of PEPD with a predominant symptom of short-lasting, severe, unilateral headache.
- 23 April 2015
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 16 (1) , 1-9
Open AccessShort-lasting unilateral neuralgiform headache attacks with ispilateral facial flushing is a new variant of paroxysmal extreme pain disorder
We encountered a 5-year-old girl who had short-lasting, severe, unilateral temporal headaches with ipsilateral lacrimation, nasal congestion and rhinorrhoea, and facial flushing after severe attacks. Family history revealed similar short-lasting, severe headaches in an older brother, younger sister, mother, maternal aunt, and maternal grandfather’s brother. We performed routine laboratory examinations and electrophysiological and radiological studies for three children, and whole-exome sequencing to determine the genetic causality in this family. Focal hyperperfusion of the right trigeminal root entry zone was seen during a right-sided attack in one child, while left-sided temporal headache attacks were provoked by bilateral electrical stimulation of the upper extremities in another. We identified a novel SCN9A mutation (NM_002977: c.5218G>C, p.Val1740Leu) in all affected family members, but not in any of the unaffected members. SCN9A encodes the voltage-gated sodium-channel type IX alpha subunit known as Nav1.7. Gain-of-function mutations in Nav1.7 are well known to cause paroxysmal extreme pain disorder (PEPD), a painful Na-channelopathy characterized by attacks of excruciating deep burning pain in the rectal, ocular, or jaw areas. The SCN9A mutation suggests that our patients had a phenotype of PEPD with a predominant symptom of short-lasting, severe, unilateral headache.